Consensus HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Market Closed - Nyse Other stock markets 01:30:02 14/09/2024 am IST			5-day change	1st Jan Change
394.68 ^USD	+0.77%		+1.73%	+45.81%

12/09	Hca Healthcare Insider Sold Shares Worth $3,221,340, According to a Recent SEC Filing	MT
05/09	Transcript : HCA Healthcare, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 03:20 PM

Evolution of the Average Target: HCA Healthcare, Inc.

Evolution of the Target Price: HCA Healthcare, Inc.

Changes in Analyst Recommendations: HCA Healthcare, Inc.

f5290bd0fc5a9f74a.cCAzcCqz3omMueCKTnuUPDrA07TiSiDfdzUzFGnyXGc.ORgCPWvln__B4NX8GE7fV22ThdeKPHi0E21bejuWaFIIcUo-R4qcsP7ziw~7a6535ef16af1b31e4027e7d835ce36d

Analysts' recommendations: HCA Healthcare, Inc.

Jefferies Adjusts Price Target on HCA Healthcare to $455 From $390	03/09	MT
Deutsche Bank Raises HCA Healthcare Price Target to $441 From $375, Maintains Buy Rating	03/09	MT
Morgan Stanley Initiates HCA Healthcare at Equalweight With $427 Price Target	03/09	MT
Wolfe Research Adjusts HCA Healthcare Price Target to $400 From $358, Maintains Outperform Rating	29/08	MT
RBC Capital Adjusts Price Target on HCA Healthcare to $405 From $378, Maintains Outperform Rating	23/08	MT
Truist Adjusts Price Target on HCA Healthcare to $430 From $390, Maintains Buy Rating	19/08	MT
UBS Adjusts Price Target on HCA Healthcare to $438 From $405, Maintains Buy Rating	14/08	MT
Hca Healthcare Insider Sold Shares Worth $1,756,695, According to a Recent SEC Filing	01/08	MT
Wells Fargo Adjusts Price Target on HCA Healthcare to $365 From $315	30/07	MT
Hca Healthcare Insider Sold Shares Worth $659,328, According to a Recent SEC Filing	30/07	MT
Goldman Sachs Adjusts Price Target on HCA Healthcare to $360 From $340	29/07	MT
Bernstein Adjusts HCA Healthcare Price Target to $392 From $362	26/07	MT
William O'Neil Initiates HCA Healthcare With Buy Rating	26/07	MT
Cantor Fitzgerald Adjusts Price Target on HCA Healthcare to $392 From $335	25/07	MT
Raymond James Adjusts HCA Healthcare's PT to $375 From $330, Maintains Outperform Rating	24/07	MT
UBS Adjusts HCA Healthcare Price Target to $405 From $377, Maintains Buy Rating	24/07	MT
TD Cowen Adjusts Price Target on HCA Healthcare to $375 From $360	24/07	MT
Barclays Adjusts Price Target on HCA Healthcare to $396 from $376	24/07	MT
Mizuho Adjusts Price Target on HCA Healthcare to $385 from $370	24/07	MT
Leerink Partners Adjusts Price Target on HCA Healthcare to $396 from $367	24/07	MT
Citigroup Adjusts Price Target on HCA Healthcare to $393 from $357	24/07	MT
Oppenheimer Adjusts Price Target on HCA Healthcare to $390 from $345	24/07	MT
RBC Raises Price Target on HCA Healthcare to $378 From $329, Keeps Outperform Rating	24/07	MT
Truist Adjusts Price Target on HCA Healthcare to $390 From $375, Maintains Buy Rating	24/07	MT
Stephens Raises HCA Healthcare's Price Target to $375 From $360	24/07	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	HCA HEALTHCARE, INC.					+0.49%
	CVS HEALTH CORPORATION					+14.09%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+1.91%
	FRESENIUS SE & CO. KGAA					+14.19%
	LABCORP HOLDINGS INC.					+14.05%
	QUEST DIAGNOSTICS INCORPORATED					+0.15%
	NATERA, INC.					+2.23%
	TENET HEALTHCARE CORPORATION					+6.12%
	UNIVERSAL HEALTH SERVICES, INC.					+3.28%
	REDE D'OR SÃO LUIZ S.A.					+13.04%
	Average					+6.95%
	Weighted average by Cap.					+6.44%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

394.68USD

Average target price

396.60USD

Spread / Average Target

+0.49%

High Price Target

455.00USD

Spread / Highest target

+15.28%

Low Price Target

316.00USD

Spread / Lowest Target

-19.94%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Argus
Wolfe Research
Jefferies & Co.
Goldman Sachs
JPMorgan Chase
Baird
UBS
DBS Bank
TD Cowen
Leerink Partners
RBC Capital Markets
Oppenheimer
Barclays
Mizuho Securities
Truist Securities
Deutsche Bank Securities
Wells Fargo Securities
Raymond James
Bernstein
Stephens Inc.
Baptista Research
Credit Suisse
Citigroup
BofA Securities
Loop Capital
Cantor Fitzgerald
Cowen
SVB Securities LLC
BMO Capital
SVB Leerink
Seaport Global Securities